Literature DB >> 25582802

Family history of mental illness or alcohol abuse and the irritable bowel syndrome.

James R Knight1, G Richard Locke2, Alan R Zinsmeister3, Cathy D Schleck3, Nicholas J Talley4.   

Abstract

OBJECTIVE: We have observed that many patients with IBS drink very little alcohol and postulated that this may reflect membership in families affected by alcoholism and mental illness. We aimed to evaluate whether a family history of substance or alcohol abuse, or psychiatric illness, is associated with IBS.
METHODS: A valid GI questionnaire was mailed to a randomly selected population-based cohort to identify IBS and healthy controls. The electronic medical record was reviewed to record the subjects' self-reported personal and family health histories.
RESULTS: A total of 2300 subjects responded (response rate 55%; IBS 13%, n=287); 230 subjects with IBS and 318 controls were eligible. Family history of alcohol/substance abuse was reported by 33% of cases and 25% of controls (OR=1.4, 95% CI=1.0-2.1, p=0.06). Family history of psychiatric illness was reported by 37% of cases and 22% of controls (OR=2.0, 95% CI=1.3-2.9, p<0.001). In the absence of a personal history of alcohol use, a family history of alcohol/substance abuse was predictive of IBS status (OR adjusted for age and gender=1.5, 95% CI=1.0-2.3, p=0.05). In the absence of a personal history of alcohol use, reporting both a family history of alcohol/substance abuse and anxiety/depression/mental illness was clearly predictive of IBS status (OR=2.5, 95% CI=1.4-4.5; p<0.005). Substance abuse as a child was associated with an increased risk of IBS (OR=2.3, 95% CI=1.1-4.8; p<0.03).
CONCLUSION: IBS is independently associated with a family history of psychiatric illness and may be linked to a family history of alcohol/substance abuse.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol; IBS; Psychiatric disease

Mesh:

Year:  2014        PMID: 25582802      PMCID: PMC4505618          DOI: 10.1016/j.jpsychores.2014.11.021

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  37 in total

1.  Genetic and environmental influences on substance initiation, use, and problem use in adolescents.

Authors:  Soo Hyun Rhee; John K Hewitt; Susan E Young; Robin P Corley; Thomas J Crowley; Michael C Stallings
Journal:  Arch Gen Psychiatry       Date:  2003-12

2.  Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities.

Authors:  G R Locke; A R Zinsmeister; N J Talley; S L Fett; L J Melton
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

3.  The patient record in epidemiology.

Authors:  L T Kurland; C A Molgaard
Journal:  Sci Am       Date:  1981-10       Impact factor: 2.142

Review 4.  Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors.

Authors:  Filippo Cremonini; Nicholas J Talley
Journal:  Gastroenterol Clin North Am       Date:  2005-06       Impact factor: 3.806

5.  Origins and consequences of age at first drink. II. Familial risk and heritability.

Authors:  M McGue; W G Iacono; L N Legrand; I Elkins
Journal:  Alcohol Clin Exp Res       Date:  2001-08       Impact factor: 3.455

6.  Epidemiology of colonic symptoms and the irritable bowel syndrome.

Authors:  N J Talley; A R Zinsmeister; C Van Dyke; L J Melton
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

7.  Functional constipation and outlet delay: a population-based study.

Authors:  N J Talley; A L Weaver; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1993-09       Impact factor: 22.682

8.  Family risk factors of alcoholism and drinking patterns among non alcoholic women: an inverse relationship? An exploratory study of female employees.

Authors:  S Vaglum; P Vaglum; O Larsen
Journal:  Scand J Soc Med       Date:  1988

9.  Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses.

Authors:  Siobhain M O'Mahony; Julian R Marchesi; Paul Scully; Caroline Codling; Anne-Marie Ceolho; Eamonn M M Quigley; John F Cryan; Timothy G Dinan
Journal:  Biol Psychiatry       Date:  2008-08-23       Impact factor: 13.382

10.  Major depression and irritable bowel syndrome: is there a relationship?

Authors:  P S Masand; D S Kaplan; S Gupta; A N Bhandary; G S Nasra; M D Kline; K L Margo
Journal:  J Clin Psychiatry       Date:  1995-08       Impact factor: 4.384

View more
  7 in total

1.  Importance of trauma-related fear in patients with irritable bowel syndrome and early adverse life events.

Authors:  Harman Rahal; Elizabeth J Videlock; Adriane Icenhour; Wendy Shih; Bruce Naliboff; Arpana Gupta; Emeran A Mayer; Lin Chang
Journal:  Neurogastroenterol Motil       Date:  2020-06-17       Impact factor: 3.598

2.  Identification of putative transcriptomic biomarkers in irritable bowel syndrome (IBS): Differential gene expression and regulation of TPH1 and SERT by vitamin D.

Authors:  Aleksandra Grozić; Keaton Coker; Christopher M Dussik; Marya S Sabir; Zhela Sabir; Arianna Bradley; Lin Zhang; Jin Park; Steven Yale; Ichiro Kaneko; Maryam Hockley; Lucinda A Harris; Tisha N Lunsford; Todd R Sandrin; Peter W Jurutka
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

Review 3.  New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Authors:  Amy E Foxx-Orenstein
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409

4.  Adverse childhood experiences are associated with irritable bowel syndrome and gastrointestinal symptom severity.

Authors:  S H Park; E J Videlock; W Shih; A P Presson; E A Mayer; L Chang
Journal:  Neurogastroenterol Motil       Date:  2016-04-08       Impact factor: 3.598

5.  Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome.

Authors:  Anthony A Fodor; Mark Pimentel; William D Chey; Anthony Lembo; Pamela L Golden; Robert J Israel; Ian M Carroll
Journal:  Gut Microbes       Date:  2018-07-18

Review 6.  Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities.

Authors:  Mark D Namba; Jonna M Leyrer-Jackson; Erin K Nagy; M Foster Olive; Janet L Neisewander
Journal:  Front Neurosci       Date:  2021-04-15       Impact factor: 4.677

7.  Risks of Major Mental Disorders and Irritable Bowel Syndrome among the Offspring of Parents with Irritable Bowel Syndrome: A Nationwide Study.

Authors:  Ta-Chuan Yeh; Ya-Mei Bai; Shih-Jen Tsai; Tzeng-Ji Chen; Chih-Sung Liang; Mu-Hong Chen
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.